TSC2 c.461C>T ;(p.T154I)

Variant ID: 16-2104421-C-T

NM_000548.3(TSC2):c.461C>T;(p.T154I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America.

Journal Of Personalized Medicine
Salvo, Mauricio M; González-Feliú, Evelin E; Toro, Jessica J; Gallegos, Iván I; Maureira, Ignacio I; Miranda-González, Nicolás N; Barajas, Olga O; Bustamante, Eva E; Ahumada, Mónica M; Colombo, Alicia A; Armisén, Ricardo R; Villamán, Camilo C; Ibañez, Carolina C; Bravo, María Loreto ML; Sanhueza, Verónica V; Spencer, M Loreto ML; de Toro, Gonzalo G; Morales, Erik E; Bizama, Carolina C; García, Patricia P; Carrasco, Ana María AM; Gutiérrez, Lorena L; Bermejo, Justo Lorenzo JL; Verdugo, Ricardo A RA; Marcelain, Katherine K
Publication Date: 2021-09-08

Variant appearance in text: TSC2: T154I
PubMed Link: 34575676
Variant Present in the following documents:
  • Main text
  • jpm-11-00899.pdf
View BVdb publication page



Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.

Oncotarget
Greenawalt, Danielle M DM; Liang, Winnie S WS; Saif, Sakina S; Johnson, Justin J; Todorov, Petar P; Dulak, Austin A; Enriquez, Daniel D; Halperin, Rebecca R; Ahmed, Ambar A; Saveliev, Vladislav V; Carpten, John J; Craig, David D; Barrett, J Carl JC; Dougherty, Brian B; Zinda, Michael M; Fawell, Stephen S; Dry, Jonathan R JR; Byth, Kate K
Publication Date: 2017-11-21

Variant appearance in text: TSC2: 461C>T
PubMed Link: 29245897
Variant Present in the following documents:
  • oncotarget-08-99237-s002.xlsx, sheet 1
View BVdb publication page